Get the Stockscreener App
3.98
3.92%
0.15
After Hours:
3.95
-0.03
-0.75%
Bioaffinity Technologies Inc stock is traded at $3.98, with a volume of 9.81M.
It is up +3.92% in the last 24 hours and up +275.47% over the past month.
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
See More
Previous Close:
$3.83
Open:
$4.3
24h Volume:
9.81M
Relative Volume:
1.23
Market Cap:
$17.90M
Revenue:
$6.16M
Net Income/Loss:
$-14.91M
P/E Ratio:
-0.373
EPS:
-10.6693
Net Cash Flow:
$-9.39M
1W Performance:
+0.25%
1M Performance:
+275.47%
6M Performance:
+37.24%
1Y Performance:
-87.83%
1-Day Range:
$3.81
$4.71
1-Week Range:
$3.40
$5.0799
52-Week Range:
$0.693
$32.10
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
3.98 | 17.23M | 6.16M | -14.91M | -9.39M | -10.67 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
bioAffinity Reports Surge in CyPath Lung Test Sales - tipranks.com
CyPath Lung sales surge 146% at bioAffinity Technologies (NASDAQ: BIAF) - Stock Titan
bioAffinity Tech Surges on Lung Cancer Study Initiative - StocksToTrade
Record Growth in bioAffinity Technologies: CyPath Lung Shines - timothysykes.com
bioAffinity reports 146% jump in Q1 lung test sales - investing.com
bioAffinity reports 146% jump in Q1 lung test sales By Investing.com - Investing.com India
Doctors drove a 146% jump in orders for this noninvasive lung test - Stock Titan
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - Stocktwits
Earnings Beat: What hedge funds are buying bioAffinity Technologies Inc Equity Warrant2026 EndofYear Setup & Fast Exit and Entry Trade Guides - baoquankhu1.vn
BioAffinity Technologies stock cools off after strong Friday rallyhere's why - MSN
bioAffinity Technologies Appoints Three New Medical and Scientific Advisory Board Members - Medical Product Outsourcing
BioAffinity shares rise as CyPath Lung growth boosts optimism - MSN
Can bioAffinity Technologies Inc lead its sector in growth2026 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Shorts Report: Is HPPPRC stock a buy or sell2026 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
Breakout Watch: Can bioAffinity Technologies Inc Equity Warrant weather a recession2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - markets.chroniclejournal.com
BIAF Stock Price, Quote & Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - chartmill.com
What's going on with bioAffinity Technologies stock Wednesday? - MSN
bioAffinity Technologies Posts New Investor Presentation Materials - tipranks.com
bioAffinity Technologies posts investor presentation materials on website - tradingview.com
bioAffinity Technologies (BIAF) shares March 2026 investor presentation materials - Stock Titan
bioAffinity Technologies Hosts Virtual Physician Roundtable on CyPath® Lung for Early Lung Cancer Detection and Pulmonary Practice Integration 123 - Minichart
bioAffinity Launches Virtual Roundtables on CyPath Lung Adoption - tipranks.com
bioAffinity Technologies (BIAF) plans CyPath Lung webinar showcasing real-world clinical use - Stock Titan
BioAffinity Technologies stock soars 120% on CyPath lung sales growth - MSN
BioAffinity’s CyPath Lung Tests Signal Powerful Growth for 2026 - timothysykes.com
BioAffinity Technologies Reports Record Growth Amid Challenges - StocksToTrade
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice - BioSpace
What's Going On With bioAffinity Technologies Stock Wednesday? - benzinga.com
bioAffinity Technologies Shows Significant Growth in Diagnostic Development - timothysykes.com
bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction - Mugglehead Magazine
Promising Biotech Stocks To ConsiderMarch 23rd - marketbeat.com
bioAffinity Technologies shares soar as investors react to upbeat CyPath Lung growth update and 2026 outlook - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
$bioAffinity Technologies (BIAF.US)$ It in to win it - Moomoo
If You Invested $1,000 in bioAffinity Tech (BIAF) - Stock Titan
What's going on with bioAffinity stock Thursday? - MSN
Big Money Moves: Is bioAffinity Technologies Inc affected by consumer sentimentRate Hike & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Why did BIAF stock surge 20% in pre-market today? - MSN
Top QCM Diagnostics (QCMD) Competitors 2026 - MarketBeat
BIAF Rises Amid Expansions and Innovations - timothysykes.com
Why is bioAffinity Technologies stock surging Tuesday? - MSN
Jobs Data: Can bioAffinity Technologies Inc lead its sector in growthPortfolio Growth Summary & Entry Point Confirmation Alerts - baoquankhu1.vn
What's Going On With bioAffinity Stock Thursday? - Benzinga
BioAffinity Technologies posts 2025 results as CyPath lung testing growth accelerates - MSN
bioAffinity Showcases CyPath Lung Case Study in Diagnostics - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CyPath Lung case study at bioAffinity (NASDAQ: BIAF) shows noninvasive option - Stock Titan
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures - Business Wire
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings - Benzinga
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):